De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Avanos Medical Beheer
Beheer criteriumcontroles 3/4
De CEO Avanos Medical's is Joe Woody, benoemd in Jun2017, heeft een ambtstermijn van 7.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 7.21M, bestaande uit 14.1% salaris en 85.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.59% van de aandelen van het bedrijf, ter waarde $ 6.15M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.1 jaar en 8.7 jaar.
Belangrijke informatie
Joe Woody
Algemeen directeur
US$7.2m
Totale compensatie
| Percentage CEO-salaris | 14.1% |
| Dienstverband CEO | 7.3yrs |
| Eigendom CEO | 0.6% |
| Management gemiddelde ambtstermijn | 4.1yrs |
| Gemiddelde ambtstermijn bestuur | 8.7yrs |
Recente managementupdates
Recent updates
There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings
Aug 07
Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate
Sep 12Avanos Medical Q2 2022 Earnings Preview
Aug 08When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
May 28Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?
Feb 10Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?
Dec 21An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued
Nov 04Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt
Sep 10The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business
Aug 10Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?
Jun 30We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt
Jun 09Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$7m |
| Mar 31 2024 | n/a | n/a | -US$2m |
| Dec 31 2023 | US$7m | US$1m | -US$10m |
| Sep 30 2023 | n/a | n/a | -US$11m |
| Jun 30 2023 | n/a | n/a | US$9m |
| Mar 31 2023 | n/a | n/a | US$18m |
| Dec 31 2022 | US$7m | US$1m | US$22m |
| Sep 30 2022 | n/a | n/a | US$23m |
| Jun 30 2022 | n/a | n/a | -US$23m |
| Mar 31 2022 | n/a | n/a | US$10m |
| Dec 31 2021 | US$5m | US$960k | -US$31m |
| Sep 30 2021 | n/a | n/a | -US$52m |
| Jun 30 2021 | n/a | n/a | US$2m |
| Mar 31 2021 | n/a | n/a | -US$38m |
| Dec 31 2020 | US$8m | US$939k | -US$29m |
| Sep 30 2020 | n/a | n/a | US$14m |
| Jun 30 2020 | n/a | n/a | -US$17m |
| Mar 31 2020 | n/a | n/a | -US$22m |
| Dec 31 2019 | US$5m | US$932k | -US$46m |
| Sep 30 2019 | n/a | n/a | -US$42m |
| Jun 30 2019 | n/a | n/a | -US$27m |
| Mar 31 2019 | n/a | n/a | -US$17m |
| Dec 31 2018 | US$6m | US$905k | -US$8m |
| Sep 30 2018 | n/a | n/a | -US$1m |
| Jun 30 2018 | n/a | n/a | -US$16m |
| Mar 31 2018 | n/a | n/a | -US$28m |
| Dec 31 2017 | US$7m | US$443k | -US$32m |
Compensatie versus markt: De totale vergoeding ($USD 7.21M ) Joe } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.23M ).
Compensatie versus inkomsten: De vergoeding van Joe is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Joe Woody (58 yo)
7.3yrs
Tenure
US$7,214,563
Compensatie
Mr. Joseph F. Woody, also known as Joe, has been Chief Executive Officer and Director of Avanos Medical, Inc. (formerly known as Halyard Health, Inc.) since June 26, 2017. He joined the Avanos Medical, Inc...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 7.3yrs | US$7.21m | 0.59% $ 5.8m | |
| Senior VP | 4.8yrs | US$2.99m | 0.13% $ 1.3m | |
| Senior VP | 3.3yrs | US$1.90m | 0.045% $ 436.1k | |
| Senior VP & Chief Commercial Officer | 5.4yrs | US$2.15m | 0.20% $ 1.9m | |
| Principal Accounting Officer & Controller | 2.5yrs | geen gegevens | 0.0091% $ 88.4k | |
| VP of FP&A and Investor Relations and Treasurer | no data | geen gegevens | geen gegevens | |
| Senior VP and Chief Ethics & Compliance Officer | 4.1yrs | geen gegevens | geen gegevens | |
| Vice President of Strategy & Corporate Development | no data | geen gegevens | geen gegevens | |
| Vice President of Human Resources | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Global R&D | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Integrated Supply Chain | less than a year | geen gegevens | geen gegevens |
4.1yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van AVNS wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 7.3yrs | US$7.21m | 0.59% $ 5.8m | |
| Independent Director | 10yrs | US$292.54k | 0.13% $ 1.2m | |
| Independent Chairman | 10yrs | US$390.00k | 0.14% $ 1.3m | |
| Independent Director | 1.6yrs | US$245.15k | 0.032% $ 311.9k | |
| Independent Director | 10yrs | US$289.38k | 0.12% $ 1.1m | |
| Independent Director | less than a year | geen gegevens | geen gegevens |
8.7yrs
Gemiddelde duur
66yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van AVNS wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.7 jaar).